drug design
Big Data and Big Pharma: A Case for Machine Learning
May 28 by Sophia BrookeSophia Booke discusses how big pharma can use machine learning to predict patient response, manage an excess of data and improve drug design
How High Level Information and Hypothesis-Driven Research can Accelerate Industrial Drug Design- Full Interview with Dr Simon Newstead
June 27 by Pharmaceuticals & Biotechnology EditorDr Simon Newstead is a lecturer in membrane protein crystallography at the University of Oxford. In this interview, he explores why uptake transporters are important in drug development and he explo...
Improving patient compliance, oral bioavailability and drug uptake using computational biology and PEPT1- Dr Simon Newstead
May 15 by Gerald ClarkeDr Simon Newstead is Lecturer in Membrane Protein Crystallography at the University of Oxford. In this interview, he explores why uptake transporters are important in drug development and he explore...
"Not Even Wrong" – The Failure of Drug-likeness Rules
March 20 by Jonas BoströmTo be honest, I am not too fond of rules in general, and drug-likeness rules in particular. That’s just me. Or, perhaps, it’s not only me. In fact, there’s an increasing amount of...
Antimicrobial Drug Development – The Past, the Present, and the Future
March 10 by Pharmaceuticals & Biotechnology EditorAntimicrobial resistance has been an issue since the introduction into clinical use of the first agents in the 1940s. Although the discovery and development of new classes of antimicrobials through th...